3-Hydroxysteroid Dehydrogenases, antagonists & inhibitors

Name
3-Hydroxysteroid Dehydrogenases, antagonists & inhibitors
Accession Number
DBCAT001271
Description
Not Available
Drugs
DrugDrug Description
TrilostaneUsed in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
Drugs & Drug Targets
DrugTargetType
Trilostane3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1target
Trilostane3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2target
TrilostaneEstrogen receptor betatarget
TrilostaneEstrogen receptor alphatarget